A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhydrosis

Trial Profile

A Phase 3, Randomized, Double-Blind, Vehicle-Controlled Efficacy and Safety Study of DRM04 in Subjects With Axillary Hyperhydrosis

Completed
Phase of Trial: Phase III

Latest Information Update: 07 Apr 2017

At a glance

  • Drugs Glycopyrrolate (Primary)
  • Indications Hyperhidrosis
  • Focus Registrational; Therapeutic Use
  • Acronyms ATMOS-1
  • Sponsors Dermira
  • Most Recent Events

    • 03 Mar 2017 Results published in a Dermira media release.
    • 03 Mar 2017 According to a Dermira media release, new data from phase 3 program (this and ATMOS-2 study) were presented in poster sessions at the 75th Annual Meeting of the American Academy of Dermatology (AAD).
    • 27 Feb 2017 According to a Dermira media release, primary results from the study will be presented during poster sessions at the 75th Annual Meeting of the American Academy of Dermatology (AAD).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top